These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report. Taniwaki M; Katsutani S; Yamasaki M; Kawamoto K; Funaishi K; Matsumoto Y; Matsumoto N; Ohashi N; Hattori N Ann Hematol; 2019 Aug; 98(8):1989-1990. PubMed ID: 30747247 [No Abstract] [Full Text] [Related]
25. Pharmacokinetic and dynamic study of levofloxacin and rifampicin in bone and joint infections. Guillaume M; Garraffo R; Bensalem M; Janssen C; Bland S; Gaillat J; Bru JP Med Mal Infect; 2012 Sep; 42(9):414-20. PubMed ID: 22944286 [TBL] [Abstract][Full Text] [Related]
26. [Prospective analysis of adverse reactions with long-term levofloxacin use]. Ryoken N Kekkaku; 2014 Jul; 89(7):643-7. PubMed ID: 25195298 [TBL] [Abstract][Full Text] [Related]
27. Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal. Park JY; Park JH; Kim SJ; Kwon JE; Kang HY; Lee ES; Kim YC J Cutan Pathol; 2017 Feb; 44(2):118-124. PubMed ID: 27766668 [TBL] [Abstract][Full Text] [Related]
28. Cutaneous pigmentation after photosensitivity induced by vandetanib therapy. Kong HH; Fine HA; Stern JB; Turner ML Arch Dermatol; 2009 Aug; 145(8):923-5. PubMed ID: 19687425 [TBL] [Abstract][Full Text] [Related]
29. Minocycline-induced blue sclera and skin hyperpigmentation. Law S BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34794979 [TBL] [Abstract][Full Text] [Related]
30. Drug-associated hyperpigmentation of the oral mucosa: report of four cases. Tosios KI; Kalogirou EM; Sklavounou A Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Mar; 125(3):e54-e66. PubMed ID: 29287748 [TBL] [Abstract][Full Text] [Related]
32. Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases. Bahloul E; Jallouli M; Garbaa S; Marzouk S; Masmoudi A; Turki H; Bahloul Z Lupus; 2017 Oct; 26(12):1304-1308. PubMed ID: 28355984 [TBL] [Abstract][Full Text] [Related]
33. Levofloxacin-induced rhabdomyolysis: a case report. John F; Oluronbi R; Pitchumoni CS J Med Case Rep; 2016 Aug; 10(1):235. PubMed ID: 27557756 [TBL] [Abstract][Full Text] [Related]
34. JAAD Grand Rounds. Posttreatment lesional hyperpigmentation. Mudigonda P; Ragland HP; Murina A J Am Acad Dermatol; 2013 May; 68(5):879-81. PubMed ID: 23602180 [No Abstract] [Full Text] [Related]
35. Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis. Liu LG; Zhu YL; Hu LF; Cheng J; Ye Y; Li JB J Antibiot (Tokyo); 2013 Dec; 66(12):709-12. PubMed ID: 23981959 [TBL] [Abstract][Full Text] [Related]
37. [Minocycline-induced hyperpigmentation: not uncommon, but nonetheless important to recognise]. Voets PJ; Blommaert D; Keijsers RR; Alkemade HA Ned Tijdschr Geneeskd; 2016; 160():D483. PubMed ID: 27879178 [TBL] [Abstract][Full Text] [Related]
38. Minocycline-induced hyperpigmentation of tympanic membrane, sclera, teeth, and pinna. Reese S; Grundfast K Laryngoscope; 2015 Nov; 125(11):2601-3. PubMed ID: 26059453 [TBL] [Abstract][Full Text] [Related]